Literature DB >> 22029037

Hypopituitarism as unusual sequelae to central nervous system tuberculosis.

S Mageshkumar1, Devendra V Patil, Aarthy J A Philo, K Madhavan.   

Abstract

Neurological tuberculosis can very rarely involve the hypophysis cerebri. We report a case of an eighteen year old female who presented with five months duration of generalised apathy, secondary amenorrhea and weight gain. She was on irregular treatment for tuberculosis of the central nervous system for the last five months. Neuroimaging revealed sellar and suprasellar tuberculomas and communicating hydrocephalus requiring emergency decompression. Endocrinological investigation showed hypopituitarism manifesting as pituitary hypothyroidism, hypocortisolism, hypogonadotropic hypogonadism, and hyperprolactinemia. Restarting anti-tuberculosis treatment, hormone replacement therapy, and a ventriculo-peritoneal shunt surgery led to remarkable improvement in the general condition of the patient.

Entities:  

Keywords:  Hyperprolactinemia; hypogonadotropism; hypopituitarism; tuberculomas

Year:  2011        PMID: 22029037      PMCID: PMC3183520          DOI: 10.4103/2230-8210.84881

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


INTRODUCTION

Tuberculosis is responsible for 20% of the intracranial space occupying lesions in India.[1] Central nervous system (CNS) tuberculosis commonly involves meninges, cerebrum, and cerebellum. Rare sites are brainstem, basal ganglia, and thalamus.[2] Tuberculomas involving hypophysis cerebri account for 1% of all intracranial tuberculomas.[1] Less than 60 cases of suprasellar tuberculomas have been reported.[1]

CASE REPORT

An 18-year-old apparently normal unmarried female was admitted with complaints of sub acute onset fever, intermittent headache, neck pain, and altered behaviour for 10 days. She had no significant illness in the past and had normal menstrual cycles. On examination, she was of thin built and febrile. Her blood pressure was 110/80 mm of Hg and had a regular pulse rate of 102 per min. She had neck stiffness. Kernig's sign was positive. Rest of the systemic examination was otherwise normal. Fundoscopy did not reveal any signs of papilledema. The investigation profile [Table 1] suggested CNS tuberculosis. Contrast-enhanced magnetic resonance imaging (MRI) of the brain showed a right thalamic infarct with multiple ring enhancing lesions in right parietal, occipital and pontine regions along with leptomeningeal enhancement [Figure 1]. There was no other identifiable tuberculous focus. She was started on intravenous dexamethasone and oral antituberculosis treatment (ATT), which included oral isoniazid, rifampicin, pyrazinamide, and ethambutol. Her condition improved. One week later she was discharged. She was asked to continue the ATT and oral prednisolone. But patient was noncompliant and lost follow-up.
Table 1

Investigation profile on first and second admission

Figure 1

(a) Axial T2-weighted MRI brain demonstrates high signal intensity infarct in right thalamus (white arrow). (b) Sagittal post contrast T1-weighted MRI brain demonstrates ring enhancing lesion (black arrow head) in pons and leptomeningeal enhancement (black arrow)

Investigation profile on first and second admission (a) Axial T2-weighted MRI brain demonstrates high signal intensity infarct in right thalamus (white arrow). (b) Sagittal post contrast T1-weighted MRI brain demonstrates ring enhancing lesion (black arrow head) in pons and leptomeningeal enhancement (black arrow) She was readmitted five months later with complaints of weight gain, secondary amenorrhea for four months, apathy, excessive somnolence and intermittent headache for two weeks, and binocular diplopia for two days. On examination, she was apathetic, withdrawn, and largely unresponsive to verbal and visual stimuli. Her blood pressure was 110/80 mm of Hg and had a regular pulse rate of 88 per min. There was neck stiffness. Kernig's sign was positive. Right lateral rectus palsy was present. Fundoscopy did not demonstrate papilledema. Investigation profile [Table 1] was again consistent with neurological tuberculosis. A computed tomography (CT) scan of the brain showed hydrocephalus with cerebral edema and so an emergency ventriculo-peritoneal shunt was done [Figure 2]. Endocrinological investigation [Table 2] revealed pituitary hypothyroidism, hypocortisolism, hypogonadotropic hypogonadism, and hyperprolactinemia. Repeat contrast-enhanced MRI of the brain revealed presence of exudates along basal cisterns and meningeal enhancement [Figure 3]. Tuberculomas were seen in sellar and suprasellar region [Figures 3 and 4].
Figure 2

(a) Noncontrast CT brain demonstrates dilated ventricles and cerebral edema. (b) Non contrast CT brain demonstrates in situ ventriculoperitoneal shunt tube

Table 2

Hormonal profile on second admission

Figure 3

Sagittal post contrast T1-weighted magnetic resonance imaging brain demonstrates smaller pontine tuberculoma (black arrow head) and sellar suprasellar and leptomeningeal enhancement (black arrow)

Figure 4

Coronal post contrast T1-weighted magnetic resonance imaging brain demonstrates sellar suprasellar enhancement (white circle)

(a) Noncontrast CT brain demonstrates dilated ventricles and cerebral edema. (b) Non contrast CT brain demonstrates in situ ventriculoperitoneal shunt tube Hormonal profile on second admission Sagittal post contrast T1-weighted magnetic resonance imaging brain demonstrates smaller pontine tuberculoma (black arrow head) and sellar suprasellar and leptomeningeal enhancement (black arrow) Coronal post contrast T1-weighted magnetic resonance imaging brain demonstrates sellar suprasellar enhancement (white circle) She was restarted on oral ATT, hydrocortisone, thyroxine, cyclical estrogen, and progesterone. Her condition dramatically improved up to an extent that she was now capable of carrying out her daily activities independently. She was discharged after rigorous counselling to remain compliant on ATT and hormone replacement therapy.

DISCUSSION

Our case is remarkable because it points to one of the very infrequently seen complication of neurological tuberculosis. Tuberculosis affection of the hypothalamus and hypophysis cerebri is a rare clinical entity. Hypothalamo-pituitary dysfunction due to tuberculosis can be due to the presence of a strategically placed tuberculoma or exudates around the sellar region. Tubercle bacilli are believed to reach the pituitary by hematogenous spread from extra cranial sources or from the infection of skull base.[2-4] Tuberculosis meningitis (TBM) has various radiological manifestations. Contrast-enhanced MRI of the brain usually shows leptomeningeal and basal cisternal enhancement, focal infarcts and tuberculomas usually surrounded by hypo attenuating edema (as seen in our case). The incidence of hydrocephalus is as high as 85% in tuberculous meningitis. It is usually of communicating type. The exact pathogenesis of hydrocephalus in tuberculous meningitis is unclear. The hydrocephalus is probably a result of adhesive meningeal reaction, obliteration of archnoid villi themselves or exudation in the subarachnoid space and cisterns of the base of the brain, around optic chiasma, interpeduncular, and prepontine cisterns. Hypothalamo pituitary dysfunction due to tuberculosis is very rare. Most of the available literature on pituitary tuberculosis is in the form of case reports. Endocrine manifestations were present in 77% of the patients with pituitary tuberculosis.[15] Headache (91%), visual symptoms (46%), anterior pituitary hypo function (58%), hyperprolactinemia (23%), diabetes insipidus (11%) are the usual manifestations seen in a meta analysis of 54 cases of pituitary tuberculosis.[145] Our patient had hypogonadotropic hypogonadism and secondary hypothyroidism, which suggests the possibility of hypopitutarism. Even when it was expected to be high in the face of tuberculosis (stress), the 8 a.m. serum fasting cortisol level was low. This suggests the presence of hypocortisolism. There was no visual field restriction, reduced visual acuity, or altered perception of red light. This suggests that there is probably no optic nerve involvement due to tuberculoma or exudation around optic chiasma. In pituitary tuberculosis, contrast-enhanced MRI characteristically demonstrates thickening of the stalk due to chronic inflammatory scarring. The thickening of the stalk is non-specific and is described in diverse conditions like neoplasm, sarcoidosis, syphilis, lymphocytic hypophysitis, granulomatous hypophysitis, and eosinophilic granuloma.[13-5] The suprasellar extension can make evaluation of the stalk difficult on neuroimaging.[6] The other MRI findings described are peripheral ring enhancement of the mass, enhancement of the adjacent dura and basal enhancing exudates, sellar or suprasellar calcification, apoplexy, and erosion of the sellar floor.[15] Our patient had T2 weighted non homogenous hyper intensities, which enhanced on contrast in the sellar, suprasellar, and basal cisterns. Although histopathological confirmation is emphasized by many authors, there are reports of pituitary tuberculosis that have been successfully managed on basis of clinical presentation and radiological findings.[5] Suprasellar tuberculosis presenting with pituitary-hypothalamic dysfunction can be differentiated from other neoplastic or inflammatory conditions on the basis of serial imaging findings, clinical profile, and response to ATT. When there is no real threat to the life or vision of the patient, then the major indication for a transphenoidal surgery would be for histopathological conformation.[2] Our patient had characteristic neuroimaging findings (tuberculomas, basal exudates, and leptomeningeal enhancement), hypoglycorrhachia and hyperproteinorrhachia suggestive of CNS tuberculosis during both admissions. The fact that the pontine lesion regressed on ATT further asserts the diagnosis of CNS tuberculosis [Figure 3]. In the background of CNS tuberculosis, noncompliance to treatment, the presence of hypothalamo-pituitary dysfunction, tuberculomas in sellar and suprasellar region almost confirms the diagnosis of pituitary tuberculosis. Noncompliance to treatment could explain the persistent hyperproteinorrhachia and the development of new tuberculomas. However, there are reports that intracranial tuberculomas can develop or enlarge during antituberculous therapy and exaggerated host reaction to tuberculous protein is thought to play a role.[2] This could probably explain the normal pituitary imaging during the first admission in our patient. However, because hormone analysis was not done during the first admission, it is not possible to rule out asymptomatic hypopituitarism. There is no standardized regimen regarding the drugs, dosages, use of steroids, and duration of treatment for CNS tuberculosis. Treatment is individualized in most of the cases. As the experience with tuberculomas of pituitary is limited, there is no consensus regarding its treatment.[5] Our patient was treated with a regimen that is usually followed for CNS tuberculosis and hormone replacement therapy.
  5 in total

1.  Suprasellar tuberculoma presenting as panhypopituitarism.

Authors:  Uma Su Sundar; Vishal V Ramteke; Meghna S Vaidya; Dyaneshwar C Asole; Nivedita D Moulick
Journal:  J Assoc Physicians India       Date:  2010-11

2.  Suprasellar tuberculoma presenting with diabetes insipidus and hypothyroidism--a case report.

Authors:  R Jain; R Kumar
Journal:  Neurol India       Date:  2001-09       Impact factor: 2.117

3.  Pituitary tuberculosis.

Authors:  K Sunil; R Menon; Naina Goel; Darshana Sanghvi; Tushar Bandgar; Shashank R Joshi; Padma Menon; Nalini Shah; A Goel
Journal:  J Assoc Physicians India       Date:  2007-06

Review 4.  Pituitary tuberculoma: magnetic resonance imaging.

Authors:  S Singh
Journal:  Neurol India       Date:  2003-12       Impact factor: 2.117

5.  Pituitary tuberculoma.

Authors:  S Shukla; A Trivedi; K Singh; V Sharma
Journal:  J Neurosci Rural Pract       Date:  2010-01
  5 in total
  1 in total

1.  Hypopituitarism in the tropics.

Authors:  Sanjay Kalra; Dinesh Dhanwal; Vaman Khadilkar
Journal:  Indian J Endocrinol Metab       Date:  2011-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.